China Pharma Holdings Operating Income 2010-2023 | CPHI
China Pharma Holdings operating income from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
China Pharma Holdings Annual Operating Income
(Millions of US $) |
| 2023 |
$-3 |
| 2022 |
$-4 |
| 2021 |
$-3 |
| 2020 |
$-3 |
| 2019 |
$-20 |
| 2018 |
$-10 |
| 2017 |
$-19 |
| 2016 |
$-8 |
| 2015 |
$-14 |
| 2014 |
$-39 |
| 2013 |
$-19 |
| 2012 |
$6 |
| 2011 |
$22 |
| 2010 |
$24 |
| 2009 |
$23 |
China Pharma Holdings Quarterly Operating Income
(Millions of US $) |
| 2023-12-31 |
$-1 |
| 2023-09-30 |
$-1 |
| 2023-06-30 |
$-0 |
| 2023-03-31 |
$-0 |
| 2022-12-31 |
$-1 |
| 2022-09-30 |
$-1 |
| 2022-06-30 |
$-1 |
| 2022-03-31 |
$-1 |
| 2021-12-31 |
$-1 |
| 2021-09-30 |
$-1 |
| 2021-06-30 |
$-1 |
| 2021-03-31 |
$-1 |
| 2020-12-31 |
$-1 |
| 2020-09-30 |
$-1 |
| 2020-06-30 |
$0 |
| 2020-03-31 |
$-1 |
| 2019-12-31 |
$-19 |
| 2019-09-30 |
$-1 |
| 2019-06-30 |
$-1 |
| 2019-03-31 |
$-0 |
| 2018-12-31 |
$-8 |
| 2018-09-30 |
$-2 |
| 2018-06-30 |
$-1 |
| 2018-03-31 |
$-0 |
| 2017-12-31 |
$-14 |
| 2017-09-30 |
$-2 |
| 2017-06-30 |
$-2 |
| 2017-03-31 |
$-1 |
| 2016-12-31 |
$-3 |
| 2016-09-30 |
$-2 |
| 2016-06-30 |
$-2 |
| 2016-03-31 |
$-1 |
| 2015-12-31 |
$-15 |
| 2015-09-30 |
$3 |
| 2015-06-30 |
$1 |
| 2015-03-31 |
$-4 |
| 2014-12-31 |
$-22 |
| 2014-09-30 |
$-6 |
| 2014-06-30 |
$-9 |
| 2014-03-31 |
$-2 |
| 2013-12-31 |
$-8 |
| 2013-09-30 |
$-3 |
| 2013-06-30 |
$-5 |
| 2013-03-31 |
$-3 |
| 2012-12-31 |
$-1 |
| 2012-09-30 |
$2 |
| 2012-06-30 |
$2 |
| 2012-03-31 |
$3 |
| 2011-12-31 |
$5 |
| 2011-09-30 |
$6 |
| 2011-06-30 |
$6 |
| 2011-03-31 |
$5 |
| 2010-12-31 |
$8 |
| 2010-09-30 |
$6 |
| 2010-06-30 |
$5 |
| 2010-03-31 |
$5 |
| 2009-12-31 |
$6 |
| 2009-09-30 |
$8 |
| 2009-06-30 |
$5 |
| 2009-03-31 |
$4 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.005B |
$0.007B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
